Expression of Concern: The efficacy of vitamin D combined with clomiphene citrate in ovulation induction in overweight women with polycystic ovary syndrome: a double blind, randomized clinical trial (Expression of Concern of Vol 69, Pg 393, 2020)

被引：0

作者：

Rasheedy, Radwa ^{[1
]}

Sammour, Hazem ^{[1
]}

Elkholy, Abdellatif ^{[1
]}

Salim, Yasmine ^{[2
]}

机构：

[1] Ain Shams Univ, Dept Obstet & Gynecol, Fac Med, Cairo, Egypt

[2] Port Said Gen Hosp, Port Said, Egypt

来源：

ENDOCRINE | 2022年 / 75卷 / 01期

关键词：

D O I：

10.1007/s12020-021-02946-0

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：315 / 315

页数：1

共 50 条

[31] Clomiphene citrate before and after withdrawal bleeding for induction of ovulation in women with polycystic ovary syndrome: Randomized cross-over trial
Elbohoty, Ahmed E. H.
Amer, Mohamed
Abdelmoaz, Mohamed
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2016, 42 (08) : 966 - 971
[32] A RANDOMIZED CONTROLLED TRIAL OF COMBINATION OF LETROZOLE AND CLOMIPHENE CITRATE VERSUS LETROZOLE ALONE FOR OVULATION INDUCTION IN WOMEN WITH POLYCYSTIC OVARY SYNDROME.
Mejia, R.
Summers, K. M.
Kresowik, J. D.
Van Voorhis, B. J.
FERTILITY AND STERILITY, 2018, 110 (04) : E29 - E30
[33] A Randomized Controlled Trial of Combination Letrozole and Clomiphene Citrate or Letrozole Alone for Ovulation Induction in Women With Polycystic Ovary Syndrome EDITORIAL COMMENT
不详
OBSTETRICAL & GYNECOLOGICAL SURVEY, 2019, 74 (06) : 349 - 350
[34] Luteal phase clomiphene citrate for ovulation induction in women with polycystic ovary syndrome: a novel protocol (vol 91, pg 838, 2009)
Badawy
FERTILITY AND STERILITY, 2020, 114 (03) : 493 - 493
[35] RETRACTION: Luteal phase clomiphene citrate for ovulation induction in women with polycystic ovary syndrome (Retraction of Vol 290, Pg 771, 2014)
Kosar, Ozlem
Ozaksit, Gulnur
Taskin, Mine Islimye
ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2023, 308 (05) : 1661 - 1661
[36] Effects of Zinc Supplementation on Endocrine Outcomes in Women with Polycystic Ovary Syndrome: a Randomized, Double-Blind, Placebo-Controlled Trial (Publication with Expression of Concern)
Jamilian, Mehri
Foroozanfard, Fatemeh
Bahmani, Fereshteh
Talaee, Rezvan
Monavari, Mahshid
Asemi, Zatollah
BIOLOGICAL TRACE ELEMENT RESEARCH, 2016, 170 (02) : 271 - 278
[37] Calcium plus vitamin D supplementation influences biomarkers of inflammation and oxidative stress in overweight and vitamin D-deficient women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial (Publication with Expression of Concern. See FEB, 2023)
Foroozanfard, Fatemeh
Jamilian, Mehri
Bahmani, Fereshteh
Talaee, Rezvan
Talaee, Naeeme
Hashemi, Teibeh
Nasri, Khadijeh
Asemi, Zatollah
Esmaillzadeh, Ahmad
CLINICAL ENDOCRINOLOGY, 2015, 83 (06) : 888 - 894
[38] RETRACTION: Combined coenzyme Q10 and clomiphene citrate for ovulation induction in clomiphene-citrate-resistant polycystic ovary syndrome (Retraction of Vol 29, Pg 119, 2014)
El Refaeey, Abdelaziz
Selem, Amal
Badawy, Ahmed
REPRODUCTIVE BIOMEDICINE ONLINE, 2023, 47 (05)
[39] Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome
Palomba, S
Orio, F
Falbo, A
Manguso, F
Russo, T
Cascella, T
Tolino, A
Carmina, E
Colao, A
Zullo, F
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (07): : 4068 - 4074
[40] The Pregnancy in Polycystic Ovary Syndrome II (PPCOS II) trial: Rationale and design of a double-blind randomized trial of clomiphene citrate and letrozole for the treatment of infertility in women with polycystic ovary syndrome
Legro, Richard S.
Kunselman, Allen R.
Brzyski, Robert G.
Casson, Peter R.
Diamond, Michael P.
Schlaff, William D.
Christman, Gregory M.
Coutifaris, Christos
Taylor, Hugh S.
Eisenberg, Esther
Santoro, Nanette
Zhang, Heping
CONTEMPORARY CLINICAL TRIALS, 2012, 33 (03) : 470 - 481

← 1 2 3 4 5 →